The investigation of signal transduction events induced by PD-L1 is ongoing, and further studies are needed in order to discover the target cytoplasmic effectors triggered by the activation of the PD-L1 molecule, as well as how those effectors are interconnected to modulate the biological events implicated in cancer progression. This evidence concerns the gene CD274 and cancer.